Novocure

Quote
GBM reps are screwed. Declining volume, crappy IC plan, no real opportunity to make money. Do you ever ask yourself why you’re still there? FL and JM ain’t going to look out for you. You’re no longer the shinny toy - just a cash cow.
Holding on to false hope s foolish! Do yourself a favor and get stepping!
 






I feel for the GBM reps. No growth and less and less opportunities to make any real money. Why are you still there? There are so manny jobs out here. I got one and you can too. The grass indeed is much greener on this side. Oh and you don’t have to work for a 3rd class management team. Even die hard loyalists left the company. What other signs are you waiting for???
 






anonymous said:
I feel for the GBM reps. No growth and less and less opportunities to make any real money. Why are you still there? There are so manny jobs out here. I got one and you can too. The grass indeed is much greener on this side. Oh and you don’t have to work for a 3rd class management team. Even die hard loyalists left the company. What other signs are you waiting for???
Click to expand...
Working on getting that other job…
 






























This company's management is a joke! They promoted LR to a Patient Director position. These unqualified people making unqualified decisions have been the downfall of this company. In regards to mass layoffs, they are coming soon because the FDA said no to lung. Novocure just doing a review of what else to trim besides the lung reps.. full on slaughter is coming in late November again, just like in 2023. For the idiots that are still here wake up fast.
 






Fake news.
anonymous said:
This company's management is a joke! They promoted LR to a Patient Director position. These unqualified people making unqualified decisions have been the downfall of this company. In regards to mass layoffs, they are coming soon because the FDA said no to lung. Novocure just doing a review of what else to trim besides the lung reps.. full on slaughter is coming in late November again, just like in 2023. For the idiots that are still here wake up fast.
Click to expand...
Fake news! When we get approval, will you come back and admit how wrong you are? Man, love CP conspiracy theories!
 






anonymous said:
This company's management is a joke! They promoted LR to a Patient Director position. These unqualified people making unqualified decisions have been the downfall of this company. In regards to mass layoffs, they are coming soon because the FDA said no to lung. Novocure just doing a review of what else to trim besides the lung reps.. full on slaughter is coming in late November again, just like in 2023. For the idiots that are still here wake up fast.
Click to expand...
I've tried finding the FDA denial online and can't. Do you have a reliable source?
 






Novocure (NVCR): FDA Approves Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer​

October 15, 2024 4:09 PM
Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for concurrent use with PD-1/PD-L1 inhibitors or docetaxel, for the treatment of adult patients with metastatic non-small cell lung cancer (mNSCLC) who have progressed on or after a platinum-based regimen.
“Novocure is committed to extending survival in some of the most aggressive and difficult to treat cancers. The approval of Optune Lua brings a new and urgently needed option for people with metastatic NSCLC who have progressed while on or after platinum-based chemotherapy,” said Asaf Danziger, CEO, Novocure. “We are grateful to the patients, caregivers, investigators and healthcare providers who supported the clinical trials that led to this approval.”
Optune Lua is a portable device that produces alternating electric fields known as tumor treating fields (TTFields), which are delivered through non-invasive, wearable arrays. TTFields exert physical forces on the electrically charged components of dividing cancer cells, resulting in cell death.
 






anonymous said:
This company's management is a joke! They promoted LR to a Patient Director position. These unqualified people making unqualified decisions have been the downfall of this company. In regards to mass layoffs, they are coming soon because the FDA said no to lung. Novocure just doing a review of what else to trim besides the lung reps.. full on slaughter is coming in late November again, just like in 2023. For the idiots that are still here wake up fast.
Click to expand...
Ready to remove that foot from your mouth?
 










































Does it matter you got the approval? Look at how the market reacted — might as well not get the approval. Embarrassing performance! You should fire your IR team. They pretty much do the opposite of what their job is all the time!! Wait isn’t your new CEO currently in charge of IR? That sums up your future outlook. #leftholdingthebag #suckeragain
 












Top Bottom
Back
Quote